Article

Shoes for ovarian cancer research

Olive Palermo shoes by Stuart Weitzman

With Breast Cancer Awareness Month already in full swing a little early, it's nice to see that September is still getting "tealed" for Ovarian Cancer Awareness Month. While cause-related marketing has become increasingly mainstream, this campaign did catch my eye. And no, I'm not a huge shoe fan. I'm more of sneakers and flip-flop kind of girl, but it was fun wondering if I'm more of a Hayden Panettiere or Olivia Palermo.

Olivia Palermo design; photo credit Stuart WeitzmanStuart Weitzman co-developed the series of shoes with four young starlets for "Young Hollywood Cares." You can view the other designs at stuartweitzman.com.Instead of stating that proceeds go to "research and awareness," as many fundraisers tend to do, all proceeds from the shoes will go directly to fund ovarian cancer research by Dr. Marsha Moses, director of the Vascular Biology Program at Children's Hospital Boston and professor at Harvard Medical School. Moses specializes in angiogenesis, a process where blood vessels grow to feed a tumor. There are numerous therapies - both approved and in development - that aim to inhibit the signals and pathways involved in angiogenesis. Here's to hoping that Scarlett Johansson's designer shoes help Dr. Moses find a breakthrough. And it just might - all four of the designers shoes are already sold out - and we still have one more week left of Ovarian Cancer Awareness Month. Too bad they didn't have a teal pair.

Related Videos
a man and a woman in front of a dark blue background for CURE Speaking Out
a man and a woman in front of a dark blue background for CURE Speaking Out
a man and a woman in front of a dark blue background for CURE Speaking Out
a man and a woman in front of a dark blue background for CURE Speaking Out
Image of woman.
Dr. Andreas M. Kaiser is a professor and chief of the Division of Colorectal Surgery in the Department of Surgery at City of Hope comprehensive cancer center in Duarte, California.
Dr. Guru Sonpavde emphasized the importance of better understanding how genetic mutations influence the treatment of cancer care, particularly GU cancers.
Image of woman with blonde hair.
Dr. Frederick L. Locke sat down with CURE® to discuss treatment with cema-cel in the ALPHA/ALPHA2 studies for relapsed/refractory large B-cell lymphoma.
Dr. Park sat down for an interview with CURE® to discuss the key takeaways from the 2025 Annual ASCO Genitourinary Cancers Symposium.
Related Content